Loading
Bard C R Inc /NJ/ is a listed company. Filings by its managers are published through SEC (Form 4). Nothing new has been filed by managers of Bard C R Inc /NJ/ in twelve months, the latest record being from 16 February 2016.
In the same market, recent insider purchases at Relmada Therapeutics, Inc. and Uber Technologies, Inc also feature in our signals. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
25 of 102 declarations
BARD C R INC is a New Jersey-based company specializing in the medical sector. It is listed on NASDAQ under the ticker BCR.
| Fiscal year end | Revenue | Net income | Diluted EPS | Dividend per share | Filing |
|---|---|---|---|---|---|
| Dec 2016 | 3.71 bn USD | 531.4 m USD | 7.03 USD | 1.02 USD | 10-K |
| Dec 2015 | 3.42 bn USD | 135.4 m USD | 1.77 USD | 0.94 USD | 10-K |
| Dec 2014 | 3.32 bn USD | 294.5 m USD | 3.76 USD | 0.87 USD | 10-K |
| Dec 2013 | 3.05 bn USD | 689.8 m USD | 8.39 USD | 0.83 USD | 10-K |
| Dec 2012 | 2.96 bn USD | 530.1 m USD | 6.16 USD | 0.79 USD | 10-K |
Amounts in USD, as filed (forms 10-K, 20-F or 40-F). Source: SEC EDGAR.